Navigation Links
Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011
Date:6/16/2011

WASHINGTON, June 16, 2011 /PRNewswire/ -- The largest human dermal allograft available on the market today for hernia and abdominal wall repair will be introduced at the AWR meeting here this week.  The Musculoskeletal Transplant Foundation (MTF), the nation's leading tissue bank, is introducing FlexHD acellular hydrated dermal matrix 20 cm x 30 cm grafts just months after releasing 20 cm x 25 cm grafts.

FlexHD large grafts can help with the most challenging general surgical and trauma procedures --

  • Reduces the need to suture smaller sheets together. The 20 cm x 30 cm size is the largest out-of-package to patient human acellular hydrated dermal matrix available for use in large abdominal wall cases and trauma.
  • FlexHD is ready when you are: it is prehydrated, so there is no waiting time, no more wrong size and no wasted time or tissue.
  • No stretching means no pre-stretching required and post-operative laxity is reduced.
  • It is natural, so you can avoid the concerns associated with xenograft products. FlexHD biologic and biomechanical properties match the human anatomy and provide rapid revascularization.
  • FlexHD superior strength and resistance to stretching make it an ideal solution for hernia repair.
  • FlexHD passes rigorous safety testing including USP <71> sterility tests. With over four million grafts distributed since its inception, MTF possesses an unrivaled safety record.

To inquire about the new sizes, contact MTF customer service at 800-433-6576 or info@mtf.org.

The Musculoskeletal Transplant Foundation, a non-profit organization, is a national consortium comprised of leading academic medical institutions, organ procurement organizations and tissue recovery organizations.  Since its inception in 1987, MTF has received tissue from more than 80,000 donors.

*FlexHD is represented by Ethicon, Inc., a Johnson & Johnson Company.

FlexHD is a trademark of Musculoskeletal Transplant Foundation.

For further information
Cindy Gordon, Insight Communication
609-252-1300


'/>"/>
SOURCE Musculoskeletal Transplant Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
10. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
11. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology:
(Date:9/26/2017)... ... September 26, 2017 , ... Data Integrity: , The Key to FDA ... 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity , Consider this situation. ... electronic records may not be trustworthy and reliable … a more detailed evaluation may ...
(Date:9/26/2017)... Milford, PA (PRWEB) , ... September 26, 2017 , ... ... month in Chicago, called “The Magic of Fat,” revealed not only the latest about ... might prove to be an evolution in cosmetic medicine. , “Fat really is magical, ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Good Morning Sunshine!: Finding ... and overcoming obstacles. “Good Morning Sunshine!: Finding Strength and Comfort in God” is the ... psychology from Fort Hays Sate University, who has worked at a local mental health ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a ... nature to the inevitable destinations of negativity, complaining and the need to always be ... take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/26/2017)... ... ... out for Daddy is a moving story of a family's unconditional love for each ... for Daddy” is the creation of published author Debra Titus, who has lived in ... her to write this book. , Published by Christian Faith Publishing, Debra Titus’s new ...
Breaking Medicine News(10 mins):